Five-year analysis on the long-term effects of dabrafenib plus trametinib (D + T) in patients with BRAF V600–mutant unresectable or metastatic melanoma.
暂无分享，去创建一个
A. Hauschild | D. Schadendorf | K. Flaherty | A. Ribas | J. Schachter | C. Garbe | P. Nathan | J. Grob | B. Karaszewska | G. Long | C. Robert | I. Bondarenko | D. Stroyakovskiy | E. Gasal | E. Levchenko | M. Tan | M. Davies | P. Burgess | Vanna Chiarion Sileni